Guthart Gary S - Oct 24, 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
CEO, Director
Signature
By: Donna Spinola For: Guthart, Gary S
Stock symbol
ISRG
Transactions as of
Oct 24, 2023
Transactions value $
-$6,806,467
Form type
4
Date filed
10/26/2023, 07:51 PM
Previous filing
Aug 11, 2023
Next filing
Jan 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $1.67M +33.8K +196.38% $49.34* 50.9K Oct 26, 2023 Direct F1
transaction ISRG Common Stock Sale -$7.12M -27.4K -53.76% $260.11 23.6K Oct 26, 2023 Direct F1, F2
transaction ISRG Common Stock Sale -$674K -2.48K -7.67% $271.93 29.8K Oct 24, 2023 by Trust FBO Daughte F1
transaction ISRG Common Stock Sale -$674K -2.48K -7.67% $271.93 29.8K Oct 24, 2023 by Trust FBO Son F1
holding ISRG Common Stock 1.18M Oct 24, 2023 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -33.8K -100% $0.00* 0 Oct 26, 2023 Common Stock 33.8K $49.34 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $256.16 to $264.24 as follows: 2,409 shares sold at $256.16 to $257.16; 3,572 shares sold at $257.17 to $258.02; 3,090 shares sold at $258.24 to $258.97; 9,133 shares sold at $259.72 to $260.69; 4,304 shares sold at $260.75 to $261.53; 2,750 shares sold at $261.93 to $262.55 and 2,127 shares sold at $264.24. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.